arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

SERA PROGNOSTICS, INC.

SERA
$2.06 ▲ +0.09 (+4.56%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
7 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

SERA PROGNOSTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $98.2M
Dividend Yield
Revenue Growth 5.2%
Op. Margin
ROIC -48.4%
FCF / Share $-0.55
Trailing P/E
Price / Book 1.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$81.00K
↑ +5.2%
Net Income Profit after all expenses
$-31.93M
↑ +2.9%
FCF / Share Free cash flow per share
$-0.55
↓ -28.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
19
Financial Health
2
Cash Quality
56

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters